0001140361-17-026146.txt : 20171101 0001140361-17-026146.hdr.sgml : 20171101 20170627060217 ACCESSION NUMBER: 0001140361-17-026146 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTIME INC CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 CORRESP 1 filename1.htm
BioTime, Inc.
1010 Atlantic Avenue, Suite 102
Alameda, California 94501

June 26, 2017

VIA EDGAR

U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:    Dorrie Yale

Re:
BioTime, Inc.
 
Registration Statement on Form S-3
 
File No. 333-218807
 
Request for Acceleration

Acceleration Request

Request Date: June 28, 2017
Request Time: 9:30 a.m. Eastern Time (or as soon thereafter as practicable)

Dear Ms. Yale:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioTime, Inc., a California corporation (the “Registrant”), hereby respectfully requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-218807), to become effective at 9:30 a.m. Eastern Time on June 28, 2017, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff (the “Staff”) of the Commission. The Registrant hereby authorizes Michael A. Hedge or Alexa M. Ekman of K&L Gates LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.

The Registrant requests that it be notified of such effectiveness by a telephone call to Michael A. Hedge at (949) 623-3519, or in his absence, Alexa M. Ekman at (949) 623-3603.

 
Sincerely,
     
 
BIOTIME, INC.
     
 
By: 
/s/ Michael D. West, Ph.D.
   
Michael D. West, Ph.D.
   
Co-Chief Executive Officer
 
cc:
Russell Skibsted, BioTime, Inc.
Stephana Patton, BioTime, Inc.
Michael A. Hedge, K&L Gates LLP
Alexa M. Ekman, K&L Gates LLP